Actavis wins FDA approval for ANDA of generic Opana ER
Oxymorphone Hydrochloride extended-release tablets, which is available in doses 5mg, 10mg, 20mg, 30mg and 40mg, is the ANDA product indicated for the relief of moderate to severe pain
Oxymorphone Hydrochloride extended-release tablets, which is available in doses 5mg, 10mg, 20mg, 30mg and 40mg, is the ANDA product indicated for the relief of moderate to severe pain
The Department of Industrial Policy & Promotion (DIPP), and the Department of Pharmaceuticals, including healthcare experts from the public health foundation of India, will participate in the discussion,
Based on the terms of the definitive agreement, the acquirer will purchase all of the issued and outstanding common shares of Medicago for $1.16 per share in cash,
Commenting on the new headquarters, Boston Biomedical chairman and DSP president and CEO Masayo Tada said that the location was surrounded by universities and research institutes that would
Under the partnership, C2N is eligible to access large quantities of highly enriched stable isotopes at predictable prices in support of its platform of Stable Isotope Labeling Kinetic
The recalled prescription only medicines include Erythromycin, Metformin, Atenolol, Pramipexole, Risperidone and Clopidogrel among others. MHRA Inspection, Enforcement and Standards director Gerald Heddell said that the move was
Designed to assess the safety, tolerability and pharmacokinetic profile of twice daily V81444 for 14 days, the study is being conducted in 24 subjects with a confirmed diagnosis
The products included in the agreement are IaluXid, a non-antibiotic, combination gel formulation treating skin infections; oral Mucositis and Xerostomia therapies GelX and GelX Xero; and Aftacure, treating
The companies have decided to pull the application as no Japanese patients were included in two longer 52-week exacerbation studies of FF/VI and the six-month clinical data on
The approval also includes a companion test to identify appropriate patients. Gilotrif is indicated for NSCLC patients whose tumors express specific types of epidermal growth factor receptor (EGFR)